MDS Pharma Services has opened an office in Sao Paulo, Brazil, to expand its global clinical trial management capabilities.
   
“Our new office in Sao Paulo is a key component of our global expansion strategy. It allows MDS Pharma Services to provide clients access to a large diverse pool of clinical trial participants and abundant healthcare resources, including more than 237,000 qualified physicians and more than 46,000 health institutions,” said MDS Pharma Services president David Spaight. “Thanks to this excellent infrastructure, clinical trials in Brazil have an impressive track record of strong enrollment rates and good patient compliance and retention. These are critical factors in allowing us to fulfill the MDS Pharma Services brand promise to deliver high-quality, on-time service to clients.”
   
In addition to the new office in Brazil, MDS offers clinical trial monitoring services in Buenos Aires, Argentina; Santiago, Chile; Lima, Peru; and Mexico City, Mexico. Since 2002, the company’s team in Latin America has conducted 33 global studies in areas such as oncology, metabolic disorders, cardiovascular, vaccines and infectious diseases.